- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07691385
Prevention of Pain Induced During Bed Bath in Ehpad (TODOMOB)
Prevention of Pain Induced During Bed Bath in Ehpad, by Adapted Mobilization Techniques : A Single Case Experimental Design (ABAB) Study
Residents of long-term care facilities are subjected to procedures and treatments that may be painful. The prevalence is 90% among older adults living in institutions. Preventing procedure-induced pain is essential, as the consequences can be even more harmful. Induced pain is defined as "short-term pain caused by a healthcare provider, treatment, or care, under predictable circumstances," according to the UPSA Pain Institute.
For these older adults, personal hygiene is performed in bed by nursing assistants and requires frequent handling and repositioning. It includes dressing and undressing, which are sources of pain. Despite this, these activities are repeated daily because they are essential. Addressing pain is a fundamental criterion for quality of life in older adults.
In many cases, these residents require daily premedication with analgesics to prevent pain caused by personal care. For these residents, who are already on multiple medications, the addition of analgesics increases the risk of drug interactions, leading to more frequent side effects.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
For residents who meet the eligibility criteria, a member of the research team-including the physician and the psychomotor therapist-meets with the resident to inform them about the study and obtain their verbal consent, if possible. If the resident is unable to give consent, the information is provided to the family or a trusted representative by phone or during a visit to the nursing home. The representative may ask the care team any questions and give oral consent after sufficient time to consider the matter.
If consent is given, the resident is then enrolled and randomized into the study.
Randomization will be based on the number of days in the first week (5, 6, or 7 days) and will be performed by the investigator in the eCRF.
The psychomotor therapist will provide expertise that the nursing assistants (NAs) will need to apply during their daily care routines throughout the pilot period in order to make care sessions less unpleasant and painful for the residents.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Vella QUILLIEN
- Telefonnummer: 01 30 75 51 75
- E-mail: vella.quillien@ght-novo.fr
Studiesteder
-
-
-
Pontoise, Frankrig
- Rekruttering
- Hôpital NOVO
-
Kontakt:
- Vella QUILLIEN
- Telefonnummer: 01 30 75 51 75
- E-mail: vella.quillien@ght-novo.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
Inclusion criteria common to all groups
- Senior residents
- With a stable Algoplus score of 2 or higher
- Information provided to and consent obtained from the resident or their trusted representative
- Eligible for intervention by a psychomotor therapist
Criteria specific to Group 1:
- Residents requiring high doses of analgesics (Level 3) before bathing
- GIR (Iso-Resource Group) 1, with multiple medical conditions
Criteria specific to Group 2:
- Residents requiring Level 1 or 2 analgesics before bathing
- GIR (Iso-Resource Group) 2 or 3, with multiple medical conditions
Criteria specific to Group 3:
- Residents experiencing pain without analgesics prior to bathing
- GIR (Iso-Resource Group) 3 or 4, with multiple medical conditions
Exclusion Criteria:
- Resident who has previously received treatment from a psychomotor therapist
- Resident capable of washing at the sink (partially) or independently
- Under guardianship, conservatorship, or judicial protection
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Resident GIR1
Resident (GIR (Iso-Resource Group) 1) requiring high doses of pain medication (Level 3) before bathing
|
Caregivers follow the standard guidelines for personal hygiene.
They are not trained by the psychomotor therapist.
Care assistants follow the psychomotor therapist's recommendations for providing appropriate personal care to residents.
A new approach to pain prevention developed by a psychomotor therapist and shared with nursing assistants who assist with bedside hygiene for residents experiencing pain of 2 or higher on the ALGOPLUS scale.
|
|
Eksperimentel: Resident GIR 2-3
Residents (GIR (Iso-Resource Group) 2 or 3) who require Level 1 or 2 analgesics before bathing
|
Caregivers follow the standard guidelines for personal hygiene.
They are not trained by the psychomotor therapist.
Care assistants follow the psychomotor therapist's recommendations for providing appropriate personal care to residents.
A new approach to pain prevention developed by a psychomotor therapist and shared with nursing assistants who assist with bedside hygiene for residents experiencing pain of 2 or higher on the ALGOPLUS scale.
|
|
Eksperimentel: Resident GIR 3-4
Residents (GIR (Iso-Resource Group) 3 or 4 ) without analgesics before bathing
|
Caregivers follow the standard guidelines for personal hygiene.
They are not trained by the psychomotor therapist.
Care assistants follow the psychomotor therapist's recommendations for providing appropriate personal care to residents.
A new approach to pain prevention developed by a psychomotor therapist and shared with nursing assistants who assist with bedside hygiene for residents experiencing pain of 2 or higher on the ALGOPLUS scale.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain reduction with ALGOPLUS
Tidsramme: 4 weeks
|
Pain measured using the ALGOPLUS scale by one independent evaluator (an experienced medical or paramedical professional) after bathing.
|
4 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Drug profile
Tidsramme: 4 weeks
|
Change in the dose of pain medication received, by 3 categories of residents
|
4 weeks
|
|
Satisfaction of care workers
Tidsramme: 4 weeks
|
Questionnaire on changes in practices and how they were perceived, before the study and after each bath
|
4 weeks
|
|
Bathing Process
Tidsramme: 4 weeks
|
Number of caregivers, duration of care
|
4 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Vella QUIILIEN, Hôpital NOVO
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 2025-A02024-45
- CHRD0925 (Anden identifikator: HOPITAL NOVO)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Ældrepleje
-
Wake Forest University Health SciencesAfsluttetSelf Geriatric Assessment Measure (SGAM)Forenede Stater
-
Xuzhou Medical UniversityIkke rekrutterer endnuIkke-invasiv CAR-T-celleovervågning | BCMA-målrettet PET-skanning | CAR-T-cellebiodistribution og -persistens | GMP-overensstemmende Radiopharmaka-præparation
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringCLL | SLL | CAR-T celleterapiKina
-
Duke UniversityNational Institutes of Health (NIH)RekrutteringHæmatopoietisk stamcelletransplantation | CAR-T celleterapiForenede Stater
-
Patrick C. Johnson, MDRekruttering
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
University Health Network, TorontoRekrutteringLymfom, der modtager CAR-T-terapiCanada
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Ikke rekrutterer endnuAllogen, CAR-T, proteinsekvestrering, ikke-genredigeretKina
Kliniske forsøg med Standard personal hygiene
-
Salisbury UniversityRekrutteringSund livsstil | Arteriel stivhedForenede Stater
-
Rambam Health Care CampusCogMe LtdRekruttering
-
The Max Stern Academic College Of Emek YezreelUkendt
-
Salisbury UniversityAfsluttetSund livsstil | Arteriel stivhedForenede Stater
-
The Hong Kong Polytechnic UniversityAfsluttetParkinsons sygdom og ParkinsonismeHong Kong
-
Global Kinetics CorporationAktiv, ikke rekrutterendeParkinsons sygdomForenede Stater
-
Mostafa ShabanTilmelding efter invitationDemens | Agitation ved demens, herunder Alzheimers sygdomEgypten
-
Kaiser PermanenteAfsluttetFedme | OvervægtigForenede Stater
-
PfizerAfsluttet
-
Candice Dunkin, MS, LAT, ATCParkview HealthAfsluttet